Skip to main content

Table 3 Relation of early anti-osteoporosis agent prescription with 1-year medical visits and expenditure

From: Improved outcomes and reduced medical costs through multidisciplinary co-management protocol for geriatric proximal femur fractures: a one-year retrospective study

  Patients not on
anti-osteoporosis agent
(n = 345)
Patients on
anti-osteoporosis agent
(n = 233)
p value  
Returns for overall medical services (1-year)       
  Number of patients returned (№) 283 (84.6%) 216 (88.4%) < 0.001**  
  Average expenditure per returned patient (NTD) 132,500 ± 258,635 111,394 ± 182,922 0.005**  
  Average expenditure per patient in treatment group (NTD) 108,688 ± 239,649 103,267 ± 178,470 < 0.001**  
Returns for outpatient clinic (1-year)       
  Number of patients returned (№) 269 (78.0%) 208 (89.3%) < 0.001**  
  Average visits per returned patient (times) 13 ± 13 13 ± 12 0.036*  
  Average expenditure per returned patient (NTD) 45,079 ± 114,539 49,585 ± 70,357 < 0.001**  
  Average expenditure per patient in treatment group (NTD) 35,149 ± 102,815 44,265 ± 68,215 < 0.001**  
Returns for emergency department (1-year)       
  Number of patients returned (№) 91 (26.4%) 66 (28.3%) 0.673  
  Average visits per returned patient (times) 2 ± 2 2 ± 2 0.332  
  Average expenditure per returned patient (NTD) 21,865 ± 24,092 21,915 ± 25,536 0.957  
  Average expenditure per patient in treatment group (NTD) 5767 ± 15,652 6208 ± 16,752 0.605  
Returns for inpatient admission (1-year)       
  Number of patients returned (№) 83 (24.1%) 52 (22.3%) 0.700  
  Average visits per returned patient (times) 2 ± 2 2 ± 1 0.779  
  Average expenditure per returned patient (NTD) 281,704 ± 303,361 236,559 ± 243,513 0.408  
  Average expenditure per patient in treatment group (NTD) 67,772 ± 190,991 52,794 ± 150,927 0.546  
  1. Mann-Whitney test. Chi-Square test. *p < 0.05, **p < 0.01
  2. Continuous data were expressed with mean ± SD
  3. Categorial data were expressed with number and percentage